The Catalysts

The Catalysts

By Schulich School of Medicine & Dentistry (Western University)ScienceEducationLife Sciences
Download on the App Store

The Catalysts episodes

  • In the Blood: The Quest to Detect Cancer Before It Returns with Dr. Ana Lohmann

    Breast cancer is the most common cancer in Canadian women, with 1 in 8 women facing a diagnosis in their lifetime. It's a complex foe, shaped by biology and lifestyle, made difficult by invasive treatments and cumbersome diagnostic techniques.

    In this episode, Dr. Ana Lohmann, a medical oncologist and scientist at Western University's Schulich School of Medicine & Dentistry, discusses how this complexity is being met head-on. Her research explores how obesity and metabolism shape cancer diagnosis and recurrence, and how lifestyle, access to care and social inequities influence outcomes. She also discusses emerging tools like liquid biopsies and the growing focus on survivorship and quality of life.

    With Dr. Ana Lohmann, MD PhD

    Medical Oncologist, Verspeeten Family Cancer Centre

    Associate Scientist, London Health Sciences Research Institute

    Assistant Professor, Western University

    Dept. of Epidemiology & Biostatistics, Dept. of Oncology

    • Breast Cancer and Obesity
    • Bio
    • Breast Cancer and Diabetes Drugs
    46 min
  • Gut Feelings: Your Microbiome and the Future of Cancer Treatment with Saman Maleki, PhD

    Can the trillions of microbes in our gut hold the key to transforming cancer treatment? Through relentless persistence, Saman Maleki, PhD, is pioneering research that uses the gut microbiome and fecal microbiota transplants (FMT) to boost the power of cancer-fighting immunotherapy. In this episode, he shares the science, the challenges, and the hope driving a new frontier in cancer care.

    With Saman Maleki, PhD

    Associate Professor, Departments of Pathology & Laboratory Medicine, Oncology, and Medical Biophysics, Schulich School of Medicine & Dentistry, Western University

    Scientist, Ontario Institute for Cancer Research (OICR)

    Scientist, Verspeeten Family Cancer Centre, London Health Sciences Centre Research Institute

    Saman Maleki's Poop Pills

    FMT Phase 1 Trials

    FMT at Work

    51 min
  • Immunity's Hidden Warriors: Fighting Cancer with MAIT Cells with Mansour Haeryfar, PhD

    What if your body already held a secret weapon to beating cancer? Mansour Haeryfar, PhD, is tapping into MAIT cells — a rare type of immune cell that can be supercharged with bacterial molecules to hunt down tumours. His research suggests these cells could form a basis for powerful, universal therapies that work across patients. In this episode, he'll reveal how this cutting-edge science could transform cancer treatment and how the inspiration to fight against malignancy came from an unexpected source.

    With Mansour Haeryfar, PhD

    Professor, Departments of Microbiology & Immunology, Medicine, Surgery, and Oncology, Schulich School of Medicine & Dentistry, Western University

    Scientist, Lawson Research Institute of St. Joseph's Health Care London

    Past President, Canadian Society for Immunology

    Robert Pope: the Artist

    MAIT Cells Fighting Cancer Tumors

    The Haeryfar Laboratory

    44 min
  • Cancer in Motion: Tracking Cells Through the Body with John Ronald

    Imagine if doctors could send tiny, living medicine straight to a tumor — and then watch it move through the body in real time. That's the work of imaging scientist John Ronald, PhD. From eureka moments, to using firefly genes to track cells, in this episode he tells us how curiosity and creativity are leading to cancer treatment breakthroughs, and opening new frontiers in cancer treatment — one where therapies can be monitored, adjusted, and optimized as scientists track their progress inside the body with unprecedented resolution.

    With John Ronald, PhD

    Associate Professor, Medical Biophysics

    Director, Imaging Laboratories, Robarts Research Institute Schulich School of Medicine and Dentistry Western University

    • John Ronald's Lab
    • Cell Tracking Research
    • Imaging Reporter Genes
    • Monitoring Cell Therapies
    41 min
  • Beyond One-Size-Fits-All Treatment: The DNA Revolution in Medicine with Dr. Richard Kim

    When it comes to cancer drug treatments, one size doesn't fit all. That's because our unique genetics determine how our body reacts to certain drugs, which can turn a life-saving treatment into a side-effect nightmare. This is the problem Dr. Richard Kim has spent his career solving. He's championed pharmacogenomics: using genetics to match the right drug to the right patient. His persistence helped make Ontario one of the first provinces to adopt genetic testing that prevents severe chemotherapy side effects, saving lives and reshaping cancer care. In this episode, Dr. Kim explains why "one-size-fits-all" medicine is outdated and how innovations in technology are turbocharging genomics and precision medicine.

    With Richard B. Kim MD, FRCPC, FCAHS, FRSC

    Wolfe Medical Research Chair in Pharmacogenomics

    Professor of Medicine, Physiology & Pharmacology, and Oncology

    Chair, Division of Clinical Pharmacology

    Department of Medicine

    Schulich School of Medicine & Dentistry, Western University

    Attending Physician, London Health Sciences Centre

    Scientist, London Health Sciences Research Institute

    • Personalized Medicine at Schulich
    • Groundbreaking Drug Testing
    • Wolfe Medical Research Chair in Pharmacogenomics
    • Pharmacogenomics in the Clinic

    53 min
  • Reading Between the Pixels: Sarah Mattonen on the Future of Cancer Imaging

    Every cancer journey begins with images—CT scans, MRIs, X-rays. For most of us, they're snapshots that confirm what's already there. But for Sarah Mattonen, PhD, at Schulich School of Medicine & Dentistry, those images hold untold stories. She's uncovering hidden patterns in scans—clues that can reveal if a tumor might come back, or if treatment could cause side effects before patients feel them. With the power of AI, she's turning medical images into roadmaps for truly personalized cancer care. In this episode, we explore how her work is transforming cancer treatment today, and what it means for the future of oncology.

    With Sarah Mattonen, PhD

    Assistant Professor of Medical Biophysics and Oncology, Schulich School of Medicine & Dentistry, Western University

    Scientist, London Health Sciences Centre Research Institute

    Cancer Imaging at the Baines Centre

    Alumni profile

    Paper in International journal of Radiation Oncology, Biology, Physics

    Paper in the Journal of Thoracic Disease

    Paper in the International Journal of Medical Physics Research and Practice

    44 min
  • A Roadmap to Hope: Rewriting Cancer Care with Dr. David Palma

    Cancer can feel like a battle fought in darkness - but what if you could turn on the lights? In this episode, Dr. David Palma, a radiation oncologist and clinician-scientist, explains how he's changing the way patients understand and fight their diagnosis. He's transformed personal loss into a mission to empower patients to become the heroes of their own medical stories. As well, as a leading expert in precision radiotherapy, he'll discuss how he's pushing the boundaries of how radiation can treat advanced cancers. With a bestselling book and decades of expertise, Dr. Palma will reveal how every patient can turn their cancer diagnoses into a roadmap to hope.

    With Dr. David Palma

    Professor, Department of Oncology , Schulich School of Medicine & Dentistry, Western University

    Radiation Oncologist, Verspeeten Family Cancer Centre, London Health Sciences Centre

    Taking Charge of Cancer, by David Palma

    Sapiens, by Yuval Noha Harari

    Precision Radiation

    Bio

    45 min
  • Ep. 6: Revitalizing the Aging Brain and Neurogenesis: An Exclusive Conversation with 2024 Taylor Prize Laureate Rusty Gage

    Join us as we delve into the groundbreaking work of 2024 Taylor Prize Laureate Professor Rusty Gage, whose landmark discovery transformed our understanding of the brain by showing that humans continue to generate new neurons well into adulthood and even as we age.

    In this episode, we explore the latest research in the field of neurogenesis and learn how Professor Gage and his team are unlocking innovative approaches to revitalizing the aging brain. We'll also get a glimpse into the inspirations behind his work—from systems theory to intriguing concepts in astrophysics—revealing how these ideas drive his pioneering research in neuroscience.

    1 hr 28 min
  • Ep. 5: The SuperAgers with Angela Roberts

    Why do some older adults in their 80s, 90s and even 100s age well? What's the secret to their excellent cognition? Is it genetics or environmental factors? Join us as we take a sneak peek into the world of the SuperAgers.

    In this episode, Western Professor Angela Roberts flips the aging problem on its head and looks at why some age exceptionally well. Discover what makes the Canadian cohort of SuperAgers extra special – a diverse group of older adults with exceptional cognition, an unquenchable thirst for life and adventure, and to top it all, resilience against time and adversity.

    53 min
  • Ep. 4: Real to surreal – a new aging experience with virtual reality with Paul Frewen

    Tune in to learn how VR can transform the aging experience – from enhancing social connections to creating mystical experiences.

    In this episode, Western professor Paul Andrew Frewen shares insights from his research on virtual reality, psychiatry, and psychology. Discover how wearable VR technology is being harnessed to enhance mental well-being, promote social connection, revolutionize mental health interventions and create profound experiences for the aging population.

    50 min

About The Catalysts

From the publisher's feed

The Catalysts is a medical science and discovery podcast produced by Schulich School of Medicine & Dentistry at Western University, Canada. The show blends expert insight with engaging stories, and connects world-class research with the people who benefit most from scientific advancement.